Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

AstraZeneca (LSE:AZN) recently announced promising clinical trial results for ENHERTU, which may reflect its ongoing commitment to enhancing therapeutic options for HER2-positive metastatic breast ...

SCIEX & Evosep expand access to standardized proteomics for pharma and biotech with new reseller agreement: Marlborough, Massachusetts Tuesday, June 3, 2025, 15:00 Hrs [IST] SCIEX ...

Representative Robert Bresnahan, Jr. recently sold Danaher shares worth between $1,001 and $15,000 on May 15th. He also made ...